Elilly介绍AI TuneLab平台, 以加速生物技术公司的药物发现。 Eli Lilly introduces AI platform TuneLab to speed up drug discovery for biotech firms.

Eli Lilly是一家主要的制药公司,它推出了TuneLab,这是一个AI平台,使生物技术公司能够利用它以价值10亿美元的研究数据建立起来的药物发现模型。 Eli Lilly, a major pharmaceutical company, has launched TuneLab, an AI platform that gives biotech firms access to its drug discovery models, built from over $1 billion worth of research data. 该倡议旨在通过利用人工智能和机器学习、提高制药业的效率和创新,加速开发新药物。 This initiative aims to accelerate the development of new drugs by leveraging AI and machine learning, enhancing the efficiency and innovation in the pharmaceutical industry.